Pulmonary and Neurologic Effects of Mesenchymal Stromal Cell Extracellular Vesicles in a Multifactorial Lung Injury Model

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Marissa A Lithopoulos - , University of Ottawa (Author)
  • Lannae Strueby - , University of Saskatchewan (Author)
  • Megan O'Reilly - , University of Alberta (Author)
  • Shumei Zhong - , University of Ottawa (Author)
  • Marius A Möbius - , Department of Paediatrics, Biotechnology Center, University Hospital Carl Gustav Carus Dresden (Author)
  • Farah Eaton - , University of Alberta (Author)
  • Moses Fung - , University of Alberta (Author)
  • Maria Hurskainen - , University of Saskatchewan (Author)
  • Chanèle Cyr-Depauw - , University of Ottawa (Author)
  • Colin Suen - , University of Ottawa (Author)
  • Liqun Xu - , University of Ottawa (Author)
  • Jennifer J P Collins - , University of Ottawa (Author)
  • Arul Vadivel - , University of Ottawa (Author)
  • Duncan J Stewart - , University of Ottawa (Author)
  • Dylan Burger - , University of Ottawa (Author)
  • Bernard Thébaud - , University of Ottawa (Author)

Abstract

Rationale: Bronchopulmonary dysplasia, a chronic respiratory condition originating from preterm birth, is associated with abnormal neurodevelopment. Currently, there is an absence of effective therapies for bronchopulmonary dysplasia and its associated brain injury. In preclinical trials, mesenchymal stromal cell therapies demonstrate promise as a therapeutic alternative for bronchopulmonary dysplasia. Objectives: To investigate whether a multifactorial neonatal mouse model of lung injury perturbs neural progenitor cell function and to assess the ability of human umbilical cord-derived mesenchymal stromal cell extracellular vesicles to mitigate pulmonary and neurologic injury. Methods: Mice at Postnatal Day 7 or 8 were injected intraperitoneally with LPS and ventilated with 40% oxygen at Postnatal Day 9 or 10 for 8 hours. Treated animals received umbilical cord-mesenchymal stromal cell-derived extracellular vesicles intratracheally preceding ventilation. Lung morphology, vascularity, and inflammation were quantified. Neural progenitor cells were isolated from the subventricular zone and hippocampus and assessed for self-renewal, in vitro differentiation ability, and transcriptional profiles. Measurements and Main Results: The multifactorial lung injury model produced alveolar and vascular rarefaction mimicking bronchopulmonary dysplasia. Neural progenitor cells from lung injury mice showed reduced neurosphere and oligodendrocyte formation, as well as inflammatory transcriptional signatures. Mice treated with mesenchymal stromal cell extracellular vesicles showed significant improvement in lung architecture, vessel formation, and inflammatory modulation. In addition, we observed significantly increased in vitro neurosphere formation and altered neural progenitor cell transcriptional signatures. Conclusions: Our multifactorial lung injury model impairs neural progenitor cell function. Observed pulmonary and neurologic alterations are mitigated by intratracheal treatment with mesenchymal stromal cell-derived extracellular vesicles.

Details

Original languageEnglish
Pages (from-to)1186-1201
Number of pages16
JournalAmerican journal of respiratory and critical care medicine
Volume205
Issue number10
Publication statusPublished - 15 May 2022
Peer-reviewedYes

External IDs

Scopus 85127421624
unpaywall 10.1164/rccm.202012-4520oc

Keywords

Keywords

  • bronchopulmonary dysplasia, extracellular vesicles, mesenchymal stromal cells, neonatal lung disease, neural progenitor cells